Jaguar Health, Inc. (JAGX): Price and Financial Metrics
JAGX Price/Volume Stats
Current price | $0.16 | 52-week high | $1.22 |
Prev. close | $0.18 | 52-week low | $0.05 |
Day low | $0.15 | Volume | 32,743,500 |
Day high | $0.17 | Avg. volume | 50,699,613 |
50-day MA | $0.09 | Dividend yield | N/A |
200-day MA | $0.27 | Market Cap | 43.34M |
JAGX Stock Price Chart Interactive Chart >
Jaguar Health, Inc. (JAGX) Company Bio
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. It operates through two reportable segments, Human Health and Animal Health. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its human health product pipelines include crofelemer, which is in Phase III clinical trial for the treatment of cancer therapy-related diarrhea, as well as for the supportive care for inflammatory bowel disease; formulation of crofelemer that is Phase II clinical trial for the treatment of short bowel syndrome, congenital diarrheal disorders, idiopathic/functional diarrhea, and irritable bowel; and SB-300, a second-generation anti-secretory agent for various indications, including cholera. The company's animal health product candidates comprise Canalevia, an animal prescription drug product candidate intended for treatment of chemotherapy-induced diarrhea in dogs; and Equilevia, a non-prescription product for total gut health in equine athletes. In addition, its products include Neonorm Calf and Neonorm Foal. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
Latest JAGX News From Around the Web
Below are the latest news stories about JAGUAR HEALTH INC that investors may wish to consider to help them evaluate JAGX as an investment opportunity.
11 Popular Penny Stocks on RobinhoodIn this article, we discuss the 11 popular penny stocks on Robinhood. If you want to skip our detailed analysis of these stocks, go directly to 5 Popular Penny Stocks on Robinhood. Even though the United States economy has battled recession fears in the past few months, there are many reasons to be optimistic about […] |
Jaguar Health, Inc. (NASDAQ:JAGX) Not Doing Enough For Some Investors As Its Shares Slump 61%Jaguar Health, Inc. ( NASDAQ:JAGX ) shareholders won't be pleased to see that the share price has had a very rough... |
A Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage IIStage II completed; comprehensive results expected in Q1 2024; company's planned regulatory pathway for FDA approval remains on trackCancer patients at patient advocacy events voice strong support for company's focus on patient quality of life and ... |
MASCC (Multinational Association of Supportive Care in Cancer) Webinar on GI Toxicities from Cancer Therapies Made Possible by Grant From Napo Pharmaceuticals, a Jaguar Health Family CompanyTo register for the webinar, click hereSAN FRANCISCO, CA / ACCESSWIRE / December 7, 2023 / Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company, today announced that a Multinational Association of Supportive Care in Cancer ... |
Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) WebsiteSAN FRANCISCO, CA / ACCESSWIRE / December 6, 2023 / Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company, today announced that the abstract for "More Than a Diagnosis: A Quality of Life Survey for Individuals with a Diagnosis ... |
JAGX Price Returns
1-mo | 102.53% |
3-mo | 57.95% |
6-mo | -50.97% |
1-year | -71.92% |
3-year | -99.95% |
5-year | -100.00% |
YTD | 5.68% |
2023 | -97.68% |
2022 | -91.64% |
2021 | -57.46% |
2020 | 1.75% |
2019 | -95.00% |
Continue Researching JAGX
Here are a few links from around the web to help you further your research on Jaguar Health Inc's stock as an investment opportunity:Jaguar Health Inc (JAGX) Stock Price | Nasdaq
Jaguar Health Inc (JAGX) Stock Quote, History and News - Yahoo Finance
Jaguar Health Inc (JAGX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...